Inovio Historical Income Statement
| INO Stock | USD 4.32 0.13 3.10% |
Historical analysis of Inovio Pharmaceuticals income statement accounts such as Total Revenue of 790.4 K or Other Operating Expenses of 74.3 M can show how well Inovio Pharmaceuticals performed in making a profits. Evaluating Inovio Pharmaceuticals income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Inovio Pharmaceuticals's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Inovio Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Inovio Pharmaceuticals is a good buy for the upcoming year.
Inovio |
About Inovio Income Statement Analysis
Inovio Pharmaceuticals Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Inovio Pharmaceuticals shareholders. The income statement also shows Inovio investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Inovio Pharmaceuticals Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Inovio Pharmaceuticals generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Operating Income
Operating Income is the amount of profit realized from Inovio Pharmaceuticals operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Inovio Pharmaceuticals is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Inovio Pharmaceuticals' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Inovio Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inovio Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Inovio Stock, please use our How to Invest in Inovio Pharmaceuticals guide.At this time, Inovio Pharmaceuticals' Total Other Income Expense Net is very stable compared to the past year. As of the 30th of November 2024, Selling General Administrative is likely to grow to about 50 M, while Depreciation And Amortization is likely to drop about 2.4 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 1.9M | 1.3M | 1.2M | 1.2M | Depreciation And Amortization | 4.7M | 5.5M | 3.5M | 2.4M |
Inovio Pharmaceuticals income statement Correlations
Click cells to compare fundamentals
Inovio Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Inovio Pharmaceuticals income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 5.5M | 4.6M | 4.7M | 5.5M | 3.5M | 2.4M | |
| Interest Expense | 7.9M | 8.7M | 1.9M | 1.3M | 1.2M | 1.2M | |
| Total Revenue | 4.1M | 7.4M | 1.8M | 10.3M | 832.0K | 790.4K | |
| Gross Profit | (83.9M) | (86.8M) | (3.0M) | 4.8M | (2.7M) | (2.5M) | |
| Other Operating Expenses | 115.2M | 131.5M | 303.0M | 277.8M | 144.8M | 74.3M | |
| Operating Income | (111.1M) | (124.1M) | (301.2M) | (267.6M) | (135.2M) | (128.5M) | |
| Ebit | (111.1M) | (154.2M) | (301.3M) | (276.4M) | (133.9M) | (127.2M) | |
| Research Development | 88.0M | 94.2M | 249.2M | 187.7M | 86.7M | 52.1M | |
| Ebitda | (105.6M) | (149.6M) | (296.6M) | (270.9M) | (130.4M) | (123.9M) | |
| Cost Of Revenue | 88.0M | 94.2M | 4.7M | 5.5M | 3.5M | 3.3M | |
| Total Operating Expenses | 115.2M | 131.5M | 303.0M | 277.8M | 132.6M | 73.5M | |
| Income Before Tax | (120.8M) | (162.9M) | (303.2M) | (277.7M) | (135.1M) | (128.4M) | |
| Total Other Income Expense Net | (9.7M) | (38.8M) | (2.0M) | (10.1M) | 109.3K | 114.8K | |
| Net Income | (120.6M) | (215.1M) | (305.4M) | (287.7M) | (135.1M) | (128.4M) | |
| Income Tax Expense | (257.3K) | 52.2M | 2.2M | 10.0M | 2.0 | 1.9 | |
| Selling General Administrative | 27.2M | 37.2M | 53.8M | 90.2M | 47.6M | 50.0M | |
| Net Income From Continuing Ops | (120.5M) | (162.9M) | (303.2M) | (277.7M) | (164.6M) | (172.8M) | |
| Non Operating Income Net Other | 1.3M | (72.9M) | 3.3M | (1.2M) | (1.1M) | (1.2M) | |
| Net Income Applicable To Common Shares | (119.4M) | (166.4M) | (303.7M) | (279.8M) | (251.8M) | (239.2M) | |
| Interest Income | 2.6M | 3.3M | 3.4M | 4.8M | 8.2M | 8.6M | |
| Net Interest Income | (5.3M) | (5.4M) | 1.4M | 3.5M | 6.9M | 7.3M | |
| Reconciled Depreciation | 5.5M | 4.6M | 4.7M | 5.5M | 4.7M | 5.3M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inovio Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Inovio Stock, please use our How to Invest in Inovio Pharmaceuticals guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inovio Pharmaceuticals. If investors know Inovio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inovio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.43) | Revenue Per Share 0.025 | Quarterly Revenue Growth (0.55) | Return On Assets (0.40) | Return On Equity (0.91) |
The market value of Inovio Pharmaceuticals is measured differently than its book value, which is the value of Inovio that is recorded on the company's balance sheet. Investors also form their own opinion of Inovio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Inovio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inovio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Inovio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inovio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Inovio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inovio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.